GEMMUS PHARMA
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
GEMMUS PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.gemmuspharma.com
Total Employee:
11+
Status:
Active
Contact:
4159781908
Email Addresses:
[email protected]
Total Funding:
5.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Office 365 Mail Google Maps ReCAPTCHA GoDaddy DNS Google Google Maps API
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
NLT SPINE
NLT SPINE develops minimally invasive spinal surgery products for the treatment of degenerative spinal conditions.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Wilmington Investor Network
Wilmington Investor Network investment in Series B - Gemmus Pharma
The Angels' Forum
The Angels' Forum investment in Series B - Gemmus Pharma
Life Science Angels
Life Science Angels investment in Series B - Gemmus Pharma
BlueTree Allied Angels
BlueTree Allied Angels investment in Series B - Gemmus Pharma
Tech Coast Angels
Tech Coast Angels investment in Series B - Gemmus Pharma
The Angels' Forum
The Angels' Forum investment in Series A - Gemmus Pharma
Wilmington Investor Network
Wilmington Investor Network investment in Series A - Gemmus Pharma
BlueTree Allied Angels
BlueTree Allied Angels investment in Series A - Gemmus Pharma
Tech Coast Angels
Tech Coast Angels investment in Series A - Gemmus Pharma
Life Science Angels
Life Science Angels investment in Series A - Gemmus Pharma
Official Site Inspections
http://www.gemmuspharma.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
